نتایج جستجو برای: vaginal dryness

تعداد نتایج: 32463  

Journal: :American family physician 2016
D Ashley Hill Mark Crider Susan R Hill

The results of large clinical trials have led physicians and patients to question the safety of hormone therapy for menopause. In the past, physicians prescribed hormone therapy to improve overall health and prevent cardiac disease, as well as for symptoms of menopause. Combined estrogen/progestogen therapy, but not estrogen alone, increases the risk of breast cancer when used for more than thr...

Journal: :Journal of Clinical Medicine 2023

Hormonal vaginal therapy is an effective treatment option for women who experience symptoms related to hormonal changes. Estrogen and prasterone are widely used as treatments, particularly urogenital atrophy. These may include dryness, itching, burning, pain during sexual intercourse, all of which can significantly affect a woman’s quality life. Previous studies have indicated that such improve...

Journal: :Journal of The American Society of Brewing Chemists 2022

The growing popularity of hard cider in the United States has been accompanied by an inconsistent understanding nature and importance consumers’ perception dryness sweetness product. In 2018, New York Cider Association proposed Merlyn Dryness Scale as a tool to predict using basic chemistry, but this approach yet be validated sensory experiments. current study, panelists (N = 48) evaluated thre...

Journal: :iranian journal of nursing and midwifery research 0
aazam parnan emamverdikhan nahid golmakani sayyed asajadi tabassi malihe hassanzadeh nooriyeh sharifi mohammad taghi shakeri

abstract background: menopause is associated with various complications such as depression, sleep disorders, and genitourinary atrophy. vaginal atrophy occurs due to the loss of steroid hormones, and its major symptoms include vaginal dryness, itching, dyspareunia, and bleeding after intercourse. according to the literature, vitamin e plays a key role in estrogen stability. the aim of this stud...

2017
Oriana M. Bezzina Peter Gallagher Sheryl Mitchell Simon J. Bowman Bridget Griffiths Victoria Hindmarsh Ben Hargreaves Elizabeth J. Price Colin T. Pease Paul Emery Peter Lanyon Michele Bombardieri Nurhan Sutcliffe Costantino Pitzalis John Hunter Monica Gupta John McLaren Anne M. Cooper Marian Regan Ian P. Giles David A. Isenberg Vadivelu Saravanan David Coady Bhaskar Dasgupta Neil J. McHugh Steven A. Young‐Min Robert J. Moots Nagui Gendi Mohammed Akil Kirsten MacKay W. Fai Ng Lucy J. Robinson Elalaine C Bacabac Robert Moots Kuntal Chakravarty Shamin Lamabadusuriya Constantino Pitzalis Rashidat Adeniba John Hamburger Andrea Richards Saaeha Rauz Sue Brailsford Joanne Logan Diarmuid Mulherin Jacqueline Andrews Alison McManus Colin Pease Alison Booth Theodoros Dimitroulas Lucy Kadiki Daljit Kaur George Kitas Mark Lloyd Lisa Moore Esther Gordon Cathy Lawson Lesley Stirton Gill Ortiz Elizabeth Price Gavin Clunie Ginny Rose Sue Cuckow Susan Knight Deborah Symmons Beverley Jones Shereen Al‐Ali Andrew Carr Katherine Collins Ian Corbett Christine Downie Suzanne Edgar Marco Carrozzo Francisco Figuereido Heather Foggo Claire Humphreys Katherine James Dennis Lendrem James Locke Iain Macleod Philip Mawson Philip Stocks Jessica Tarn Adrian Jones Alice Muir Paula White Steven Young‐Min Susan Pugmire Saravanan Vadivelu Annie Cooper Marianne Watkins Anne Field Stephen Kaye Devesh Mewar Patricia Medcalf Pamela Tomlinson Debbie Whiteside Neil McHugh John Pauling Julie James Nike Olaitan Jayne McDermott Olivia Godia Elizabeth Kidd Lynne Palmer Victoria Katsande Pamela Long Charles Li Usha Chandra Stefano Fedele Ada Ferenkeh‐Koroma Ian Giles David Isenberg Helena Maconnell Stephen Porter Paul Allcoat

OBJECTIVE To develop a novel method for capturing the discrepancy between objective tests and subjective dryness symptoms (a sensitivity scale) and to explore predictors of dryness sensitivity. METHODS Archive data from the UK Primary Sjögren's Syndrome Registry (n = 688) were used. Patients were classified on a scale from -5 (stoical) to +5 (sensitive) depending on the degree of discrepancy ...

Journal: :Seminars in reproductive medicine 2005
Susan A Ballagh

Reduction of ovarian steroids at menopause leads to significant changes in the urogenital tract. These changes often worsen with time, particularly in nonsmokers, affecting up to 38% of menopausal women. Urogenital symptoms that clearly respond to estrogen therapy include atrophic vaginitis, dryness, and accompanying dyspareunia. Estrogen reduces urinary tract infections in women plagued by fre...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2008
M Hickey C Saunders A Partridge N Santoro H Joffe V Stearns

BACKGROUND The purpose of this study was to provide practical, evidence-based guidelines for evaluating and treating common menopausal symptoms following breast cancer. METHODS Literature review of the causes, assessment and management of menopausal symptoms in breast cancer patients. RESULTS A number of nonhormonal treatments are effective in treating hot flashes. Whether pharmacological t...

2001

The benefits of conventional estrogen replacement therapy (ERT) with regards to reduction or elimination of vasomotor symptoms, prevention of urogenital atrophy, protection against osteoporosis, reduction of cardiovascular risk and improvement in cognition in postmenopausal (PM) women are generally well accepted. However there is still inadequacy of current ERT in the treatment of sexual sympto...

Journal: :Nutrition reviews 2005
Gail B Mahady

For many years, hormone replacement therapy (HRT) was considered the gold standard for the symptomatic treatment of menopause. Clinical trials have found that HRT reduces the symptoms of hot flashes and sweating, while also decreasing vaginal dryness and urinary tract infections. HRT has also been shown to be protective against colon cancer (37%) and hip fractures (34%). However, recent finding...

2011

The menopause, defined as the end of the last menstrual period, occurs at a median age of 53 years (Hardy 2005). The change in hormone levels during the perimenopause and menopause, particularly the decline in levels of oestrogen, can cause acute menopausal symptoms; for example, about 30–70% of women in Western countries will experience vasomotor symptoms, such as hot flushes and night sweats ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید